Question 7. Have you traveled internationally within the past 14 days (please answer 'Yes' or 'No')? If yes, please list where? o
Question 7. Local Principal Investigator ☐MH Principal Investigator’s name Question 8: Attach the approved PROTOCOL provided by the IRB of Record BASIC LOCAL SITE INFORMATION: Only one of the following will apply: ☐Enter 'ALL' if MetroHealth will perform all study related procedures. ☐If not performing all study related procedures, describe what procedures will be performed at MetroHealth EXTERNAL IRB:
Question 7. The Contract states that “Any communication to CCEE shall be made to . . . three . . . individuals” from the CCEE and the Fiscal Agent. Do all communications, including invoices, need to go to all three individuals? Response 7: Any formal correspondence must go to all three individuals. An example of formal correspondence might include a notice to terminate the contract. Invoices and other routine correspondence should simply be directed at the proper individual. Question 8: I am not sure how to comply with the insurance requirements (Section II, Paragraph L). Please advise.
Examples of Question 7 in a sentence
After completing Question 6, go to Question 7 if stratification is used.
GUIDELINES: Question 7 asks if multi-year expenditure estimates are presented by any one of the three expenditure classifications — by administrative, economic, and functional classifications — which were addressed in Questions 1-5 above.
Please keep in mind the daily and aggregate caps placed on any pay for paid sick leave and expanded family and medical leave as described in the answer to Question 7.
This response should align with the intervention-specific list included in the response to Question 7 in the Hospital Application.Please note, hospitals are also required to complete the Intervention Proposal below for statewide priorities identified in Question 6 of the HTP Hospital Application.Please use the unique identification code from the Performance Measures List (which is available on the HTP website) to identify your selected measures.
If your organization had audit findings on any project identified in your response to Question 7, please specify the project, briefly state those findings, and describe how your organization resolved them.
More Definitions of Question 7
Question 7. The instructions in L.2.1.3 state that, “The Offeror needs to provide a plan for evaluating each program element, see Section 2 of the PWS.” There is no Section 2 of the PWS that is defined – can the Government provide Section 2 of the PWS? Government’s response: Volume 1: Factor 1 – Management, subset (3) on page 63 of the solicitation is revised to read:
Question 7. So we have a choice? We don’t have to pick just one vendor off of the contract? Answer 7: No. Use the contract effectively by using all the vendors. Compare prices, compare quality of service you receive, compare the products, how easy is their website for you to navigate? Is their customer service department efficient when you need their assistance? Did their account representative contact you and offer their services in helping you learn to order from the contract? Question 8: Still have questions?
Question 7. Are former guarantees higher than provided by this Section maintained? Decision: Yes. Question 8: May runs of under 80 miles in each direction be placed on a one-way basis and a minimum day allowed in each direction? Decision: Yes, if definitely assigned, in which case overtime rules applicable to through passenger service in effect shall apply.
Question 7. Are former guarantees higher than provided by this Section maintained? Decision: Yes.
Question 7. What is the approximate budget of the project? Answer: The approximate budget for Construction is $3,000,000.00. At the end of the design, the City of Port Orange expects a full estimate of the Construction costs.
Question 7. How does the License & Distribution Agreement (“LDA”) affect the transaction accounting? GeneLink entered into the LDA agreement with GeneElite, an unrelated company as discussed in the “Overview” above. GeneLink is to receive under the LDA $1,500,000 which includes a $750,000 non-refundable advance deposit as discussed further below. This represents $250,000 for the Athletic Formula Channel, and $1,250,000 for the Direct Sales and MLM Channels. $1,000,000 (the "Upfront License Fee") was paid upon execution of the LDA and $500,000 (the "Remaining License Fee") shall be payable when GeneLink's shareholders have approved the sale of GeneWize Life Sciences, Inc. to Capsalus Corp. pursuant to the Shareholders Meeting. The LDA contains an additional clause in Schedule 3.2. See Attachment A, Note 11 related to a $750,000 non-refundable advance deposit (“NDA”) which shall be used solely and exclusively by GeneLink to improve or support its infrastructure and to improve or support its capability to manufacture, ship and deliver Products and otherwise handle and process Customer orders. This NDA is to be credited back to Gene Elite at $1 per order of products over the term of the contract and represents a portion of the Up Front Payment of $1,000,000. The NDA accrues interest at 4% per annum. Based on these terms, we believe the NDA is more akin to a line of credit and as the Purchaser pays for products purchased from GeneLink, the NDA will be reduced at $1 per order (defined in the LDA as “each shipment to a Customer”). Therefore, the NDA should be recorded as a liability at the date of receipt and should be reduced for any shipments to customers with the offsetting amount recorded against any amounts due from the Purchaser for purchase of its products. Revenue recognition for the other $750,000 of the total $1,500,000 (the actual “License Fees” does not appear to be within the scope of ASC revenue recognition guidance for specific intellectual property transactions such as collaborative arrangements, franchisors, etc. Therefore, guidance falls under the general guidance for ASC 605. We do note however, that the SEC has also provided their interpretations for similar fees as documented below. Per ASC 605-10-S99 (SEC Materials)
Question 7. 10: (Goal 2, Objective 2A&B; Goal 3, Objective 3A&B) • Indicate the 17th XX XXXX xxxxx funded service/activity for reporting period. (refer to your Goals and Objectives on your grant application) *Report only on the progress of the goals set forth in your grant application. • Include number of victims served, specific service(s) provided and grant recipient agency personnel providing service; number of persons trained, specific training(s) conducted and grant recipient agency conducting training, etc. • Enter N/A if not funded for Goal 2, Objective 2A, 2B or Goal 3, Objective 3A or 3B